MORRISVILLE, N.C., May 10, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that on May 7, 2021, it resubmitted its New Drug Application (NDA) for LIQ861 for the treatment of pulmonary arterial hypertension (PAH). The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding […]
Coronary/Structural Heart
Prevent Heart Disease, Interview With Dr. Rajiv Agarwal of Modern Heart & Vascular Institute
Dr. Rajiv Agarwal (Cardiologist) with Modern Heart & Vascular Institute discusses who should get heart screening and how the latest technology can help. HOUSTON, May 7, 2021 /PRNewswire/ — In April, 2021, Dr. Rajiv Agarwal, board-certified cardiologist at Modern Heart and Vascular Institute, talked about the importance of heart screening. He helped clear up some myths […]
Daxor Corporation Receives National Institutes of Health (NIH) Funding Notification for Landmark Multi-Center Heart Failure Trial Utilizing the BVA-100® (Blood Volume Analyzer) with the United States Department of Veterans Affairs
NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces the initiation of a multi-center clinical trial with two Veterans Affairs Medical Centers to evaluate Blood Volume Analysis guided management of acute decompensated heart failure (ADHF) utilizing […]
HeartFlow and MedAxiom Announce Collaboration to Improve Care Delivery for Patients with Coronary Artery Disease
REDWOOD CITY, Calif. & NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, and MedAxiom, an American College of Cardiology (ACC) company whose mission is to transform cardiovascular care and improve heart health, announced today a collaboration to improve cardiovascular care for patients with coronary artery disease (CAD). The […]
Robocath successfully completes first robotic coronary angioplasties in Belgium
Rouen, France, May 4, 2021 – Robocath, a company that designs, develops and commercializes cardiovascular robotic platforms for the treatment of vascular diseases, today announces the successful completion of first five robotic coronary angioplasties in Belgium. The Percutaneous Coronary Interventions (PCI) were performed on April 8 and 13 by Prof. Stefan Verheye, […]
American Society for Preventive Cardiology to Partner with Vindico Medical Education for CE Educational Symposium: Saving the Hearts of Women with Prevention
JACKSONVILLE, Fla., May 4, 2021 /PRNewswire/ — The American Society for Preventive Cardiology (ASPC) is thrilled to partner with Vindico Medical Education on an educational symposium: Saving the Hearts of Women with Prevention during the ASPC 2021 Virtual Summit on CVD Prevention: Protecting the Heart of One and All. This initiative is an important addition to […]
Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to Enrollment
Next Cohort to Enroll Patients on Background Therapy of Disopyramide SOUTH SAN FRANCISCO, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the opening of enrollment in Cohort 3 of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM), an ongoing Phase 2 clinical trial of CK-3773274 (CK-274), a […]
High risk heart patients underuse hospice care options
National Partnership for Healthcare and Hospice Partnership in collaboration with the American Heart Association are working to improve quality and access to hospice and palliative/advanced illness care May 03, 2021 15:02 ET | Source: National Partnership for Healthcare and Hospice Innovation Dallas and Washington, D.C., May 03, 2021 (GLOBE NEWSWIRE) — Despite […]
Prevencio and Seattle Children’s Research Institute Present Highly Accurate Data for First Time Artificial Intelligence-driven Multiple Protein Blood Test for Kawasaki Disease
Kawasaki Disease—a critical childhood disease—linked to COVID-19 KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces presentation of highly accurate data on an Artificial Intelligence (AI)-driven blood test for Kawasaki disease (KD) at the Pediatric Academic Societies (PAS) International Sessions. The novel test, HART KD, was jointly developed with Seattle Children’s Research Institute and […]
Medtronic Announces CE Mark of Evolut™ PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
As TAVI Patient Population Grows, PRO+ TAVI System Launches with Four Valve Sizes and Lowest Delivery Profile DUBLIN, May 3, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark of the Evolut™ PRO+ TAVI System – the newest-generation Medtronic TAVI system that builds off […]



